http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210136161-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C331-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20210136161-A
titleOfInvention Diarylhydantoin compounds
abstract The present invention relates to diarylhydantoin compounds, including diarylthiohydantoin, and methods for their synthesis, and to their use in the treatment of hormone refractory prostate cancer.
priorityDate 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422449404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951627
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413383495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411980438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422389290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66722049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148804955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11957756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422569831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467194292

Total number of triples: 45.